BONANNI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 22.923
EU - Europa 19.969
AS - Asia 12.144
SA - Sud America 1.817
AF - Africa 370
OC - Oceania 265
Continente sconosciuto - Info sul continente non disponibili 6
Totale 57.494
Nazione #
US - Stati Uniti d'America 22.597
RU - Federazione Russa 5.807
PL - Polonia 5.239
SG - Singapore 3.393
IT - Italia 3.330
CN - Cina 2.643
HK - Hong Kong 1.875
BR - Brasile 1.420
VN - Vietnam 1.377
IE - Irlanda 1.310
SE - Svezia 1.074
KR - Corea 1.053
FI - Finlandia 659
FR - Francia 656
DE - Germania 602
IN - India 465
GB - Regno Unito 374
UA - Ucraina 255
AU - Australia 253
JO - Giordania 229
TR - Turchia 202
ID - Indonesia 188
CH - Svizzera 177
CA - Canada 173
NL - Olanda 168
JP - Giappone 165
AR - Argentina 149
BD - Bangladesh 137
ES - Italia 100
CI - Costa d'Avorio 80
MX - Messico 79
ZA - Sudafrica 74
EC - Ecuador 67
IQ - Iraq 67
PK - Pakistan 50
CO - Colombia 48
PH - Filippine 48
NG - Nigeria 44
EG - Egitto 34
PE - Perù 32
VE - Venezuela 31
MA - Marocco 30
PY - Paraguay 30
CZ - Repubblica Ceca 27
MY - Malesia 27
BE - Belgio 26
UZ - Uzbekistan 26
AE - Emirati Arabi Uniti 23
CL - Cile 22
SA - Arabia Saudita 22
BG - Bulgaria 19
LT - Lituania 19
TH - Thailandia 19
TN - Tunisia 18
AT - Austria 16
KE - Kenya 16
SC - Seychelles 16
AL - Albania 15
BH - Bahrain 14
DO - Repubblica Dominicana 14
DZ - Algeria 14
RO - Romania 13
GE - Georgia 12
IL - Israele 12
JM - Giamaica 12
PT - Portogallo 12
UY - Uruguay 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
LV - Lettonia 10
OM - Oman 10
TW - Taiwan 10
NO - Norvegia 9
GT - Guatemala 8
IR - Iran 8
NZ - Nuova Zelanda 8
SV - El Salvador 8
BO - Bolivia 7
HN - Honduras 7
KG - Kirghizistan 7
NP - Nepal 7
SN - Senegal 7
BJ - Benin 6
CR - Costa Rica 6
ET - Etiopia 6
GR - Grecia 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
EE - Estonia 5
LU - Lussemburgo 5
MD - Moldavia 5
QA - Qatar 5
SI - Slovenia 5
AM - Armenia 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
FJ - Figi 4
HR - Croazia 4
LB - Libano 4
Totale 57.422
Città #
Warsaw 5.216
Santa Clara 5.022
Ashburn 2.482
Singapore 2.431
Fairfield 1.596
Hong Kong 1.543
Dublin 1.306
Chandler 1.089
Seoul 1.034
San Jose 953
Seattle 683
Woodbridge 664
Cambridge 623
Beijing 578
Houston 556
Wilmington 543
Florence 491
Hefei 487
Ho Chi Minh City 426
Buffalo 398
Princeton 389
Los Angeles 362
Lauterbourg 358
Jacksonville 355
Lawrence 351
The Dalles 330
Altamura 322
Council Bluffs 322
Moscow 311
Hanoi 308
Boston 306
Helsinki 278
Mumbai 276
New York 269
Ann Arbor 252
Milan 214
Melbourne 206
Rome 201
Boardman 200
Munich 163
Tokyo 157
Bern 151
Jakarta 143
Medford 140
Kent 127
San Diego 127
Shanghai 127
Dallas 112
São Paulo 110
Paris 103
Izmir 101
Chicago 96
Clifton 95
Turku 85
Dong Ket 83
Abidjan 80
London 77
Frankfurt am Main 73
Redondo Beach 69
Orem 68
Norwalk 65
Naples 63
Toronto 62
Rio de Janeiro 60
Bologna 59
Da Nang 57
Lappeenranta 57
Barcelona 56
Montreal 51
Phoenix 46
Brooklyn 45
Dearborn 45
Haiphong 45
Genoa 44
Bremen 41
Falls Church 41
Hillsboro 40
Abuja 39
Chennai 37
Guangzhou 36
Atlanta 34
Turin 34
Palermo 32
Tianjin 32
Amsterdam 31
Andover 31
Falkenstein 30
Bari 28
Lima 28
Manchester 28
Bengaluru 27
Denver 27
Johannesburg 27
Yubileyny 27
Salerno 26
Porto Alegre 25
Tashkent 25
Guayaquil 23
Brasília 22
Curitiba 22
Totale 37.566
Nome #
Manuale di igiene e sanità pubblica 637
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 584
HPV vaccination for boys? A systematic review of economic studies 445
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 410
Beliefs and Opinions of Health Care Workers and Students Regarding Influenza and Influenza Vaccination in Tuscany, Central Italy 346
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 331
A summer school on vaccinology: Responding to identified gaps in pre-service immunisation training of future health care workers. 322
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 315
Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy 314
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis 307
Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants’ vaccination? 305
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015 304
Primary hepatitis A vaccination failure is a rare although possible event: results of a retrospective study 302
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines 302
Preventing and managing herpes zoster: key actions to foster healthy aging 302
Budget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy 300
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 297
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 295
Human papilloma virus vaccination: impact and recommendations across the world. 292
Coverage or Efficacy: Which Factor is the Most Influential for Reducing Varicella with Routine Childhood Vaccination in Italy? 292
Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: Where is the greatest benefit for cervical cancer prevention in Italy? 290
Monitoring the web to support vaccine coverage: Results of two years of the portal VaccinarSì 288
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 286
[The 2014 lifetime immunization schedule approved by the Italian scientific societies. Italian Society of Hygiene, Preventive Medicine, and Public Health. Italian Society of Pediatrics. Italian Federation of Pediatric Physicians. Italian Federation of General Medical Physicians. Arezzo Service of Legal Medicine] 278
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 278
Varicella vaccination in Europe – taking the practical approach 272
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 271
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 269
Detection and genotyping of human papillomavirus in urine samples from unvaccinated male and female adolescents in Italy. 267
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 266
The epidemiology of mumps in Italy 263
The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries. 256
The epidemiology of Varicella Zoster Virus infection in Italy. 256
Lifelong vaccination as a key disease-prevention strategy 253
New Italian immunisation plan is built on scientific evidence: Carlo Signorelli and colleagues reply to news article by Michael Day 252
Incidence of infection-associated cancers in Italy and prevention strategies 252
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 250
Fake news and covid-19 in Italy: Results of a quantitative observational study 238
Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy 237
Human Papilloma Virus Vaccination and Cervical Screening in the Italian Regions: An Overview of the Current State of the Art 236
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 235
Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy 234
Erratum: Corrigendum to “Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines” (Vaccine (2016) 34(6) (757–761) (S0264410X15018745) (10.1016/j.vaccine.2015.12.063)) 233
A new meningococcal B vaccine for adolescents and adults: characteristics and methods of use 228
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 226
Electronic Package Leaflets for Vaccines: What Are People's Perceptions in Italy? 223
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 222
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 218
The "Fluad Case" in Italy: Could it have been dealt differently? 217
Vaccination as a social practice: towards a definition of personal, community, population, and organizational vaccine literacy 214
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 213
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 212
The burden of hospitalization due to HPV infections in Tuscany, Central Italy 212
Economic burden of HPV9-related diseases: a real-world cost analysis from Italy 204
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 200
Progress in Italy in control and elimination of measles and congenital rubella. 200
Recommended vaccinations for asplenic and hyposplenic adult patients 198
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 197
Attitudes and perceptions of Italian Students in Healthcare Settings on COVID-19 vaccines and vaccinations strategies, one year after the immunization campaign 195
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 195
Assessing vaccine hesitancy among healthcare workers: A cross-sectional study at an Italian paediatric hospital and the development of a healthcare worker’s vaccination compliance index 194
Measles outbreak in Grosseto, central Italy, 2006. 190
The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting 190
Knowledge and training of Italian students in Healthcare Settings on COVID-19 vaccines and vaccination strategies, one year after the immunization campaign 187
[Flu vaccination and value-based health care: operational solutions to safeguard public health] 184
Knowledge of University Students in Health Care Settings on Vaccines and Vaccinations Strategies: Impact Evaluation of a Specific Educational Training Course during the COVID-19 Pandemic Period in Italy 180
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 180
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 177
Le vaccinazioni 177
SORVEGLIANZA DEGLI EVENTI AVVERSI AI VACCINI SEGNALATI IN TOSCANA NEL 2015 177
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 176
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 176
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 175
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 173
Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy 171
An overview on the implementation of HPV vaccination in Europe. 171
The experience of vaccinarsintoscana website and the role of new media in promoting vaccination 168
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 168
Vaccine safety evaluation: Practical aspects in assessing benefits and risks 168
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 167
Attitudes and Perceptions of University Students in Healthcare Settings towards Vaccines and Vaccinations Strategies during the COVID-19 Pandemic Period in Italy 166
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control 166
Valutazione del rischio di morbillo, rosolia e parotite negli operatori sanitari dell’azienda sanitaria di Firenze (ASF) 166
Health literacy and vaccination: A systematic review 166
Key points for the decision maker 166
Attitudes and beliefs on influenza vaccination during the covid-19 pandemic: Results from a representative italian survey 165
Adiuvanti e vaccini coniugati 164
Utility of healthcare system-based interventions in improving the uptake of influenza vaccination in healthcare workers at long-term care facilities: A systematic review. 164
Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review 164
Reasons for the Intention to Refuse COVID-19 Vaccination and Their Association with Preferred Sources of Information in a Nationwide, Population-Based Sample in Italy, before COVID-19 Vaccines Roll Out 164
Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence 163
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 163
The role of health literacy in covid-19 preventive behaviors and infection risk perception: Evidence from a population-based sample of essential frontline workers during the lockdown in the province of prato (tuscany, italy) 163
Influenza vaccination 2014-2015: Results of a survey conducted among general practitioners in Italy. 162
Analisi delle reazioni avverse alla prima dose di vaccini antimorbillo e antivaricella in Toscana dal 2011-2014. 162
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 162
Analisi costo-efficacia della vaccinazione anti-meningococcica con vaccino coniugato quadrivalente ACYW135 in Italia. 162
A study of hepatitis a seroprevalence in a paediatric and adolescent population of the province of florence (Italy) in the period 2017–2018 confirms tuscany a low endemic area 162
Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the implementation of universal vaccination 160
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. 160
Totale 23.355
Categoria #
all - tutte 159.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021358 0 0 0 0 0 0 0 0 0 0 137 221
2021/20222.208 80 260 140 85 54 68 66 211 73 99 353 719
2022/20235.906 579 942 292 367 386 1.084 776 330 695 49 197 209
2023/20242.704 123 258 438 187 164 293 155 367 108 237 211 163
2024/202516.708 610 1.805 1.129 2.404 4.474 2.129 385 943 889 536 636 768
2025/202617.456 2.078 2.506 1.643 1.709 1.919 726 2.414 916 1.457 1.374 714 0
Totale 57.925